World NGS Market 2017 Forecasts: Next Generation Sequencing Reviewed By Platforms And Bioinformatics


ReportsnReports.com offers Next Generation Sequencing (NGS) Market Research Report with 2017 Forecasts and Analysis of NGS Platforms and Bioinformatics


Published on 13 February 2014

Friendship Bands by Phoebe's Phashion ™Play The World's BIGGEST LOTTERY!

by Priyank Tiwari

(WireNews+Co)

Dallas, TX

Market Research Reports
Market Research Reports

The global NGS market was valued at $1.3 billion in 2012 and is poised to reach $2.7 billion by 2017. By supporting genomics research, various government bodies like NHGRI (National Human Genome Research Institute, U.S.) and Biotechnology and Biological Sciences Research Council (BBSRC, U.K.) are increasing the adoption of high-throughput sequencing platforms.

The growth of the overall NGS market is driven by continuous innovations and developments in the market aimed at higher throughput, increased accuracy, and affordable costs. However, factors such as high reliability on grants and funding from the government, and decrease in capital expenditure from academic institutions are hindering the growth of the market. In addition, the interpretation of big data generated by sequencers and the subsequent storage and management of the analyzed data is still a challenge. Owing to the complexity of NGS technologies and data, standardization of the overall NGS workflow presents an unmet need. The opportunities for the growth of this market include developments in the pre-sequencing, cloud computing, and NGS bioinformatics solutions.

The NGS platforms market was dominated by Illumina in 2012, which accounted for the largest market share of 56%. Other companies with commercial platforms include Life Technologies (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The recently introduced Bench-top and NGS platforms will drive the market. Based on steps in the NGS workflow, the overall NGS market has three major segments, namely, pre-sequencing, NGS platforms and services, and NGS data analysis, storage and management.

The raw sequencing data generated by today’s sequencers does not reflect on any meaningful information in itself. Also, open source tools for analyzing NGS data require adequate bioinformatics training. These factors open up huge opportunities for commercial NGS bioinformatics software, workbenches, and services, whose market is currently fragmented and has a relatively smaller size. Whole genome sequencing, targeted re-sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and methyl-Seq are the major applications that use NGS data analysis tools and services.

Companies profiled in this next generation sequencing market report include 454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Inc., BGI (Beijing Genomics Institute), Biomatters, Ltd., CLC Bio, Dnastar, Inc., EMC Corporation, GATC biotech AG, Genomatix Software GMBH, Illumina, Inc., Knome, Inc., Life Technologies Corporation, Macrogen, Inc., Ocimum Biosolutions, Ltd., Oxford Nanorpore Technologies, Ltd., Pacific Biosciences, Partek Incorporated, Perkinelmer, Inc., Qiagen N.V. and Strand Life Sciences Pvt. Ltd. Table of Contents and more for this report is available at http://www.reportsnreports.com/reports/257153-next-generation-sequencing-ngs-market-platforms-illumina-hiseq-miseq-life-technologies-ion-proton-pgm-454-roche-bioinformatics-rna-seq-chip-seq-pyrosequencing-sbs-smrt-diagnostics-personalized-medicine-global-forecast-to-2017.html.

Next generation sequencing is set to revolutionize applied markets like diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research. Research institutes and government bodies contribute the highest to the end-user market of NGS; however, the adoption rate in hospitals will increase in the near future due to cost effectiveness, high throughput, and sensitivity.

The NGS market will witness a whole new generation of sequencing platforms based on nanapore sequencing technology and fully integrated instruments that could perform all the NGS workflow steps.

Scope of the Report

This research report categorizes and analyzes the global NGS market on the basis of steps in the NGS workflow and NGS applications. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Global NGS market, by steps in workflow

  • Pre-sequencing Products and Services
  • DNA fragmentation and size selection
  • Library preparation
  • Target enrichment
  • Quality control
  • Sequencing Platforms, Consumables/Reagents and Services
  • Illumina
  • HiSeq Series
  • Genome Analyzer IIx
  • HiScanSQ
  • MiSeq
  • Life Technologies
  • SOLiD Series
  • Ion PGM (Personal Genome Machine)
  • Ion Proton
  • 454 Lifesciences (Roche)
  • GS Junior
  • GS FLX+
  • Pacific Biosciences
  • PacBio RS II
  • Others
  • Sequencing Services
  • NGS Data Analysis/Bioinformatics
  • By product
  • NGS data analysis software and workbenches
  • NGS data analysis services
  • NGS storage management and cloud computing solutions
  • By application
  • Whole Genome Sequencing
  • Targeted Resequencing
  • De novo Sequencing
  • RNA-Seq
  • ChIP-Seq
  • Methyl-Seq
  • Others

Global NGS market, by Technology

  • Sequencing by synthesis (SBS)
  • Ion semiconductor sequencing
  • Sequencing by ligation (SBL)
  • Pyrosequencing
  • Single molecule, real-time (SMRT) Sequencing

Global NGS market, by Application

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture and Animal Research
  • Others

NGS market, by Geography

  • North America
  • Europe
  • Asia
  • RoW (Africa, LATAM, Middle-East, Pacific countries)

Buy a copy of the report Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017 at http://www.reportsnreports.com/Purchase.aspx?name=257153.

Explore more reports on the biotechnology market at http://www.reportsnreports.com/market-research/biotechnology.


ReportsnReports.com is an online market research reports library of 400,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need. Not limited to the biotechnology industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, consumer goods, environment, pharmaceuticals, healthcare, food and beverages, medical devices, retail, water, advanced materials and much more.


Contacts

Enter your email:
Enter Subject:
Enter your message:
Please enter this numbers in the fields:
 
  Click image to get a new code.
Enter code:
 

Posted 2014-02-13 06:53:00